Revision of Prior Period Financial Statements (Details) - Schedule of restatement on balance sheet - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 15, 2021
As Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption	$ 128,744,590	$ 116,095,120
Common stock	459	465
Additional paid-in capital		5,004,068
Balance Sheet at March 31, 2021
Accumulated deficit	$ 5,084,297
Statement of Operations for the three months ended March 31, 2021
Basic and diluted weighted average shares outstanding, common stock subject to redemption (in Shares)	2,059,408
Basic and diluted weighted average shares outstanding, common stock (in Shares)	3,856,614
Basic and diluted net income (loss) per share, common stock subject to redemption (in Dollars per share)	$ 0.00
Basic and diluted net income (loss) per share, common stock not subject to redemption (in Dollars per share)	$ (0.02)
Statement of Cash Flows for the three months ended March 31, 2021
Initial value of common stock subject to possible redemption	$ 115,841,700
Change in value of common stock subject to possible redemption	12,902,890
Reclassification of offering costs related to public shares
Subsequent measurement of common stock subject to redemption against APIC
Subsequent measurement of common stock subject to redemption against APIC (interest earned on trust account)
Adjustments [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption	4,255,935	3,904,880
Common stock	(43)	(39)
Additional paid-in capital		(4,158,254)
Balance Sheet at March 31, 2021
Accumulated deficit	$ (4,255,892)
Statement of Operations for the three months ended March 31, 2021
Basic and diluted weighted average shares outstanding, common stock subject to redemption (in Shares)	247,259
Basic and diluted weighted average shares outstanding, common stock (in Shares)	(514,481)
Basic and diluted net income (loss) per share, common stock subject to redemption (in Dollars per share)	$ 2.93
Basic and diluted net income (loss) per share, common stock not subject to redemption (in Dollars per share)	$ (2.03)
Statement of Cash Flows for the three months ended March 31, 2021
Initial value of common stock subject to possible redemption	$ 8,572,213
Change in value of common stock subject to possible redemption	(12,902,365)
Reclassification of offering costs related to public shares	(2,886,166)
Subsequent measurement of common stock subject to redemption against APIC	11,472,253
Subsequent measurement of common stock subject to redemption against APIC (interest earned on trust account)	525
As Revised [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption	133,000,525	120,000,000
Common stock	416	426
Additional paid-in capital		$ 845,814
Balance Sheet at March 31, 2021
Accumulated deficit	$ 828,405
Statement of Operations for the three months ended March 31, 2021
Basic and diluted weighted average shares outstanding, common stock subject to redemption (in Shares)	2,306,667
Basic and diluted weighted average shares outstanding, common stock (in Shares)	3,342,133
Basic and diluted net income (loss) per share, common stock subject to redemption (in Dollars per share)	$ 2.93
Basic and diluted net income (loss) per share, common stock not subject to redemption (in Dollars per share)	$ (2.05)
Statement of Cash Flows for the three months ended March 31, 2021
Initial value of common stock subject to possible redemption	$ 124,413,913
Reclassification of offering costs related to public shares	(2,886,166)
Subsequent measurement of common stock subject to redemption against APIC	11,472,253
Subsequent measurement of common stock subject to redemption against APIC (interest earned on trust account)	$ 525